Investors Menu
Tilray, Inc. Reports Second Quarter 2019 Financial Results
Revenue Rises 371.1% to $45.9 (C$60.9) Million in the Second Quarter Compared to the Prior Year Period Canadian Adult-Use Revenue Nearly Doubles to $15.0 (C$20.0) Million Compared to Prior Quarter Key Investments Made in Europe and the U.S. as Part of Ongoing Focus on Global Expansion NANAIMO,
August 13, 2019
Tilray to Report Second Quarter 2019 Financial Results on August 13, 2019
NANAIMO, British Columbia --(BUSINESS WIRE)--Jul. 30, 2019-- Tilray Inc. (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, announced today it will report results for the second quarter ended June 30, 2019 on Tuesday, August 13, 2019 after market close.
July 30, 2019
Tilray® Expands European Leadership Team with Five Senior Appointments
Top talent from European pharmaceutical and beverage industries join Tilray’s leadership team as company accelerates growth in international markets NANAIMO, British Columbia --(BUSINESS WIRE)--Jul. 5, 2019-- Today, Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis production, research,
July 5, 2019
Tilray® Imports Bulk Supply of Medical Cannabis Oil into the United Kingdom
NANAIMO, British Columbia --(BUSINESS WIRE)--Jun. 25, 2019-- Tilray Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced it has imported medical cannabis oral solutions in bulk into the United Kingdom from its Good Manufacturing
June 25, 2019